1,127
Views
0
CrossRef citations to date
0
Altmetric
Articles

Inflammation markers in virologically suppressed HIV-Infected patients after switching to dolutegravir plus lamivudine vs continuing triple therapy: 48-week results in real-life setting

, , , , , ORCID Icon, & show all
Pages 28-36 | Received 02 Nov 2021, Accepted 17 May 2022, Published online: 27 Jun 2022